PerkinElmer CSO talks strategy around Caliper, Geospiza buyouts; NRC wants to tie molecular data into EHRs

> BGI has unveiled new bioinformatics analysis tools and an open-access database for "big data" projects. News

> The contract research organization INC Research says that it plans to offer its customers a host of tools from the analytics firm SAS. Release

> Stanford University researchers have developed software to analyze cancer images faster than a human doctor. The next challenge is scaling up the system for practical use. Article

> Knome, which provides genomic data interpretation, said that its new informatics service called knomeBASE "transforms raw sequence data from human genomes into a format optimized for interpretation by geneticists seeking to understand the basis of human disease or drug response." Release

> In case you missed it, InformationWeek had an interesting article about the National Research Council's report that recommends including molecular data in electronic health records, which could provide useful disease data to doctors and medical researchers. Report

> Analytics software firm SAS plans to tap patient data and expertise from UNC-Chapel Hill's Lineberger Comprehensive Cancer Center to support the development of its SAS Health Outcomes Analysis product. Story

> Bio-IT World talked to PerkinElmer ($PKI) Chief Scientific Officer Dan Marshak about the company's strategy for buying genomic analysis software firm Geospiza and Caliper Life Sciences. Interview

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.